A Nonhematopoietic Erythropoietin Analogue, ARA 290, Inhibits Macrophage Activation and Prevents Damage to Transplanted Islets
Masaaki Watanabe(Kitasato University), Makiko Kumagai‐Braesch(Karolinska University Hospital), Michael Brines(Northwell Health), Claes‐Göran Östenson(Karolinska Institutet), Torbjörn Lundgren(Araim Pharmaceuticals (United States)), Yu Saito(Tokushima University), Anthony Cerami(Araim Pharmaceuticals (United States))
Cited by 31
Related Papers
Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE)
|The Lancet Oncology|2013|1.6k
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Effects of long-term exposure to air pollution on natural-cause mortality: an analysis of 22 European cohorts within the multicentre ESCAPE project
|The Lancet|2013|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k